Search
Research
Closed Loop Study – Day and Night Feasibility StudyA Closed-Loop System will potentially have a major impact upon acute and chronic complications of diabetes as well as upon their quality of life.
Research
Aussi-AdDITInvestigating changes in retinopathy, aortic intima media thickness & heart rate variability, indicators of macrovascular disease & autonomic neuropathy
Research
Epidemiology of hypoglycaemia in childhood-onset diabetes in Western AustraliaInvestigating the demographic, lifestyle and diabetes management factors associated with the incidence of severe hypoglycemia
Research
The Kids KimberleyThe aim of establishing a local presence is based upon an intention to be by invitation considered as part of the Kimberley group of organisations as well ...
Research
Indigenous Capacity Building Grant (ICBG)This was a five year grant from the NHMRC to build research capacity in ten Aboriginal researchers
Research
Mechanisms of IgE sensitizationThis project investigates how cells of the immune system respond to substances to cause allergies to help develop new treatments.
Research
Characterization of “bystander” effects of the diphtheria-pertussis-tetanus (DTP) vaccine on the IgE systemWe are seeking more detailed information on how the immune system of infants responds to the vaccine, with the aim of identifying which aspects of the immune r
Research
Family Study of Ear Health and Metabolic Diseases in a Western Australian Aboriginal CommunityTo determine whether these extreme manifestations of disease are associated with rare or novel genetic variants in a Western Australian Aboriginal population.
News & Events
Community collaboration ensures ending RHD is everybody’s businessCollaboration is the driving force behind ‘END RHD Demonstration Communities’ – a new community-driven, research-backed approach to tackling rheumatic heart disease (RHD) in remote Australia.
Research
A phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety and tolerability of V114 in healthy infants (PNEULINK)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical